Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

dalbavancin

dalbavancin
  • Restricted Miscellaneous Programs
  • Restricted Dalvance --> restricted to outpatient use OR use in ER by ID physician
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Dalvance POWDER FOR INJECTION, INTRAVENOUS 500 mg      


Comments:

Restricted to (1) outpatient use or (2) use in ED by ID physician.

Dalbavancin is the preferred lipoglycopeptide in the outpatient or ED setting.

For Updated Formulary Preferred Products (Inpatient and Outpatient): Preferred Products for Select Agents 

 

If ordered for an inpatient by an infectious disease specialist in an attempt to expedite discharge, may be used with proper administrative approval (contact a member of AMT).
If after-hours or weekend, please send patient name, FIN, and ID provider ordering the medication to HHRxAMT@hhsys.org.


Automatic renal adjustment per guidelines. See Antimicrobial Dosing Guideline and Renal Adjustment Policy (Adult) for more information.  CrCl calculation policy available here.


Reviewed: 15 December 2015 and 28 March 2017

Updated: November 2021


Last updated: Jul. 16, 2024
  • Formulary, Not Routinely Stocked: Dalvance --> 500 mg







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.